UBS Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-45,050
| Closed | -$10.4K | – | 9461 |
|
|
2024
Q4 | $10.4K | Buy |
45,050
+28,322
| +169% | +$6.51K | ﹤0.01% | 7063 |
|
|
2024
Q3 | $36K | Sell |
16,728
-4,825
| -22% | -$10.4K | ﹤0.01% | 5833 |
|
|
2024
Q2 | $111K | Buy |
21,553
+21,532
| +102,533% | +$111K | ﹤0.01% | 4974 |
|
|
2024
Q1 | $112 | Buy |
+21
| New | +$112 | ﹤0.01% | 7651 |
|
|
2023
Q4 | – | Sell |
-1,093
| Closed | -$4.32K | – | 8702 |
|
|
2023
Q3 | $4.32K | Buy |
+1,093
| New | +$4.32K | ﹤0.01% | 6307 |
|
|
2022
Q4 | – | Sell |
-50
| Closed | – | – | 9908 |
|
|
2022
Q3 | $0 | Sell |
50
-109
| -69% | – | ﹤0.01% | 9825 |
|
|
2022
Q2 | $1K | Buy |
159
+109
| +218% | +$686 | ﹤0.01% | 8965 |
|
|
2022
Q1 | $1K | Sell |
50
-2,616
| -98% | -$52.3K | ﹤0.01% | 8897 |
|
|
2021
Q4 | $87K | Buy |
2,666
+2,186
| +455% | +$71.3K | ﹤0.01% | 5364 |
|
|
2021
Q3 | $21K | Sell |
480
-862
| -64% | -$37.7K | ﹤0.01% | 5988 |
|
|
2021
Q2 | $73K | Buy |
1,342
+1,006
| +299% | +$54.7K | ﹤0.01% | 5063 |
|
|
2021
Q1 | $25K | Sell |
336
-954
| -74% | -$71K | ﹤0.01% | 6166 |
|
|
2020
Q4 | $140K | Buy |
1,290
+670
| +108% | +$72.7K | ﹤0.01% | 4498 |
|
|
2020
Q3 | $55K | Sell |
620
-681
| -52% | -$60.4K | ﹤0.01% | 4739 |
|
|
2020
Q2 | $139K | Sell |
1,301
-373
| -22% | -$39.9K | ﹤0.01% | 4254 |
|
|
2020
Q1 | $99K | Sell |
1,674
-2,775
| -62% | -$164K | ﹤0.01% | 4447 |
|
|
2019
Q4 | $307K | Buy |
4,449
+2,185
| +97% | +$151K | ﹤0.01% | 4289 |
|
|
2019
Q3 | $235K | Buy |
2,264
+1,684
| +290% | +$175K | ﹤0.01% | 4241 |
|
|
2019
Q2 | $53K | Buy |
580
+79
| +16% | +$7.22K | ﹤0.01% | 5020 |
|
|
2019
Q1 | $46K | Buy |
501
+245
| +96% | +$22.5K | ﹤0.01% | 4803 |
|
|
2018
Q4 | $14K | Sell |
256
-948
| -79% | -$51.8K | ﹤0.01% | 6131 |
|
|
2018
Q3 | $144K | Buy |
1,204
+529
| +78% | +$63.3K | ﹤0.01% | 4440 |
|
|
2018
Q2 | $69K | Buy |
675
+411
| +156% | +$42K | ﹤0.01% | 4851 |
|
|
2018
Q1 | $34K | Sell |
264
-87
| -25% | -$11.2K | ﹤0.01% | 5142 |
|
|
2017
Q4 | $35K | Buy |
351
+241
| +219% | +$24K | ﹤0.01% | 5169 |
|
|
2017
Q3 | $16K | Buy |
110
+29
| +36% | +$4.22K | ﹤0.01% | 5708 |
|
|
2017
Q2 | $13K | Buy |
81
+3
| +4% | +$481 | ﹤0.01% | 5665 |
|
|
2017
Q1 | $12K | Sell |
78
-19
| -20% | -$2.92K | ﹤0.01% | 5592 |
|
|
2016
Q4 | $12K | Buy |
+97
| New | +$12K | ﹤0.01% | 5870 |
|